Publications by authors named "Alessandro Inno"

Claim this Profile
T
Time to Combinatorial Regimens: SGLT2i and PCSK9i in High-Risk Cardio-Oncology Patients.
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Martina Iovine, Raffaele Arianna, Alessandro Inno

J Cardiovasc Pharmacol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient data.
Andrea Ossato, Luna Del Bono, Lorenzo Gasperoni, Alessandro Inno, Vera Damuzzo

J Chemother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
KT2440-induced RBM47 regulates non-small cell lung cancer stem cell properties and T cell-mediated antitumor activity.
Qiu-Xiang Zheng, Bao-Ling Guo, Yun-Shan Jiang, Rong-Rong Zhong, Nagashree Seetharamu, Alessandro Inno

J Thorac Dis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Cardiovascular disease in adult cancer survivors: a new frontier for cardio-oncology].
Andrea Tedeschi, Maria Laura Canale, Alessandra Greco, Alessandro Inno, Marzia De Biasio

G Ital Cardiol (Rome)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A New Era, New Risks: The Cardio-Oncology Perspective on Immunotherapy in Non-Small Cell Lung Cancer.
Luigi Tarantini, Giuseppina Gallucci, Alessandro Inno, Andrea Camerini, Maria Laura Canale

Cancers (Basel)· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Cardiovascular Toxicity of Immunotherapy: Too Important to Ignore.
Andrea Camerini, Alessandro Inno, Maria Laura Canale, Stefano Oliva, Andrea Tedeschi

Int J Mol Sci· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Transformer-based AI approach to unravel long-term, time-dependent prognostic complexity in patients with advanced NSCLC and PD-L1 ≥50%: insights from the pembrolizumab 5-year global registry.
Alessio Cortellini, Valentina Santo, Leonardo Brunetti, Edoardo Garbo, David J Pinato, Alessandro Inno

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness and safety of first-line chemoimmunotherapy combinations in metastatic non-small cell lung cancer with programmed death ligand-1 < 50%: results from an Italian observational study.
Alessandro Inno, Antonello Veccia, Ettore D'Argento, Floriana Morgillo, Elio Gregory Pizzutilo

Cancer Immunol Immunother· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PCSK9 Inhibitor Inclisiran Attenuates Cardiotoxicity Induced by Sequential Anthracycline and Trastuzumab Exposure via NLRP3 and MyD88 Pathway Inhibition.
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Martina Iovine, Matteo Barbato, Alessandro Inno

Int J Mol Sci· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of metastatic ALK-positive non-small cell lung cancer: indirect comparison of different ALK inhibitors using reconstructed patient data.
Vera Damuzzo, Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato, Alessandro Inno

Front Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardio-Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity.
Vincenzo Quagliariello, Annabella Di Mauro, Gerardo Ferrara, Francesca Bruzzese, Giuseppe Palma, Alessandro Inno

Antioxidants (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGLT2 Inhibitors in Cancer Patients: A Comprehensive Review of Clinical, Biochemical, and Therapeutic Implications in Cardio-Oncology.
Alessandra Greco, Maria Laura Canale, Vincenzo Quagliariello, Stefano Oliva, Andrea Tedeschi, Alessandro Inno

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In the Era of Cardiovascular-Kidney-Metabolic Syndrome in Cardio-Oncology: From Pathogenesis to Prevention and Therapy.
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Ilaria Giacobbe, Martina Iovine, Alessandro Inno

Cancers (Basel)· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh.
Roberto Tessari, Andrea Ossato, Francesca Realdon, Valentina Montresor, Giuseppe Giovagnoni, Alessandro Inno

Hosp Pharm· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
:
: a Python package for simplifying cBioPortal data access in cancer research.
Matteo Valerio, Alessandro Inno, Stefania Gori

JAMIA Open· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of 5-year survival in patients with advanced NSCLC with PD-L1≥50% treated with first-line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry.
Alessio Cortellini, Leonardo Brunetti, Giuseppina Rita Di Fazio, Edoardo Garbo, David J Pinato, Alessandro Inno

J Immunother Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherosclerosis and the Bidirectional Relationship Between Cancer and Cardiovascular Disease: From Bench to Bedside, Part 2 Management.
Giuseppina Gallucci, Mario Larocca, Alessandro Navazio, Fabio Maria Turazza, Alessandro Inno

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials.
Andrea Messori, Andrea Ossato, Lorenzo Gasperoni, Luna Del Bono, Alessandro Inno

Curr Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Atherosclerosis, cancer and immune checkpoint inhibitors].
Maria Laura Canale, Alessandra Greco, Alessandro Inno, Andrea Tedeschi, Marzia De Biasio

G Ital Cardiol (Rome)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients.
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, Martina Iovine, Vienna Giordano, Alessandro Inno

Int J Mol Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deep Neural Network Integrated into Network-Based Stratification (D3NS): A Method to Uncover Cancer Subtypes from Somatic Mutations.
Matteo Valerio, Alessandro Inno, Alberto Zambelli, Laura Cortesi, Domenica Lorusso

Cancers (Basel)· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Addressing Post-Acute COVID-19 Syndrome in Cancer Patients, from Visceral Obesity and Myosteatosis to Systemic Inflammation: Implications in Cardio-Onco-Metabolism.
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, Carlo Maurea, Domenico Gabrielli, Alessandro Inno

Biomedicines· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Distribution characteristics and prognosis of tumor-infiltrating lymphocytes in the brain metastases of small cell lung cancer: a retrospective cohort study.
Hesheng Qian, Jingdan Pang, Chang Wan, Xinkuan Mei, Jinhua Liao, Alessandro Inno

Transl Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The sGCa Vericiguat Exhibit Cardioprotective and Anti-Sarcopenic Effects through NLRP-3 Pathways: Potential Benefits for Anthracycline-Treated Cancer Patients.
Vincenzo Quagliariello, Massimiliano Berretta, Irma Bisceglia, Ilaria Giacobbe, Martina Iovine, Alessandro Inno

Cancers (Basel)· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atherosclerosis and the Bidirectional Relationship between Cancer and Cardiovascular Disease: From Bench to Bedside-Part 1.
Giuseppina Gallucci, Fabio Maria Turazza, Alessandro Inno, Maria Laura Canale, Nicola Silvestris

Int J Mol Sci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis